reporter: chairman bennie thompson publicly claiming the january 6th house select committee will not refer former president trump or anyone else to the justice department for criminal prosecution. what i prefer that we complete our work and seal that work with the department of justice. and they will make that call after that. reporter: even without a referral, the justice department would prosecute. but some committee members feel those comments are premature. we have had a discussion about that. i thought we discovered that decision until we concluded our investigation, at least that s my understanding. reporter: vice chair liz cheney pushing back on thompson s statement. writing in a tweet, the january 6th select committee has not issued a conclusion regarding potential criminal referrals. despite the discord in the committee, attorney general merrick garland said he s monitoring its findings. i am watching. and i will be watching all the hearings. and i can as
the president s visit comes as his administration is facing mounting pressure following this, you know, 41-year inflation high that we re seeing and a huge surge in gas prices. the nation s national average for gas, $5.02 a gallon now. all of this as a key inflation measure slowed slightly last month. also this morning, the white house is now confirming that the president will be traveling to the middle east, specifically to israel and saudi arabia, in july. we re also learning his visit will include a meeting with the saudi crown prince, mohammed bin salman. remember, president biden had previously called the kingdom a pariah for its role in the killing of washington post journalist jamal khashoggi. that was before he became president. we ll have much more on that in a moment. plus, the january 6th committee is postponing now a hearing that was scheduled for tomorrow. a member of the committee saying this was due to technical issues. we ll be live on capitol hill with
learned trump s inner circle told him the fraud claims were false. within the committee, a significant public split over whether to send a criminal referral to the doj, and so that s where we want to begin today with democratic congresswoman of virginia who is on the select committee. she s joining us now. thank you so much for taking the time, congresswoman. the chairman says that a criminal referral is not going to happen. i know you and other committee members say that s not been decided. why isn t everyone on the same page? well, what i d say is it s correct that this hasn t been decided. we haven t got ton that point yet as far as the committee making a formal decision. the chairman says it s not going to happen. he went that far. well, we are continuing to have discussions within the committee, and i would say that this is something that is a very important topic for us to decide and decide as a whole committee, and we will make that decision and that announcement
received nine mrna vaccinations. she says everything so far is so good. i had one last immuno, last september, of which i also had a c.a.t. scan at that time, and it was negative for pancreatic cancer. and everybody is celebrating. but whatever time i had, it s given me more time to enjoy my grandchildren and my children and my life. it is such promising science. and it s so cool. i mean, we re talking about individualized immunotherapy. basically teaching your body to fight your own specific cancer. as you heard there, these are early days. as you mentioned it s been happening for some time, it s worked, but now these trials are just now under way, phase one trials are finishing up, phase two, phase three to come. look if this works,
work in about 20% of patients. so about 80% of the time, the current immunotherapies are not very effective. reporter: so the doctor teamed up with biontech. you may remember them as the developer of an mrna covid-19 vaccine. their goal to begin trialing mrna as a pancreatic cancer treatment. i was willing to try whatever would prevent me from having a shorter life than i really wanted to have. reporter: cancer has challenged scientists for years. in part because the cells continuously mutate, making them harder for the immune system to detect. but that s exactly why biontech s co-founders have been working with mrna for decades to see if they could outsmart cancer. how do you know it is specific really to that cancer and not to healthy human cells in that particular patient s body?